Herbas VPB

Print
EN | LT
LT - COMBINATIONS OF INHIBITORS OF MEK, EGFR AND ERBB2 IN THE TREATMENT OF KRAS-MUTANT LUNG CANCER
EN - COMBINATIONS OF INHIBITORS OF MEK, EGFR AND ERBB2 IN THE TREATMENT OF KRAS-MUTANT LUNG CANCER

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 45/06
A61P 35/00
A61K 31/4184
A61K 31/517
A61K 31/5377
A61K 31/519
European patent
(11) Number of the document 2968564
(13) Kind of document T
(96) European patent application number 14714409.1
Date of filing the European patent application 2014-03-12
(97) Date of publication of the European application 2016-01-20
(45) Date of publication and mention of the grant of the patent 2019-05-08
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/NL2014/050148
Date 2014-03-12
PCT application publication
(87) Number WO 2014/142660
Date 2014-09-18
Priority applications
(30) Number Date Country code
2010440 2013-03-12 NL
Inventors
(72)
SUN, Chong, NL
BERNARDS, Rene, NL
Grantee
(73) Stichting Het Nederlands Kanker Instituut- Antoni van Leeuwenhoek Ziekenhuis, Plesmanlaan 121, 1066 CX Amsterdam, NL
Title
(54) COMBINATIONS OF INHIBITORS OF MEK, EGFR AND ERBB2 IN THE TREATMENT OF KRAS-MUTANT LUNG CANCER
  COMBINATIONS OF INHIBITORS OF MEK, EGFR AND ERBB2 IN THE TREATMENT OF KRAS-MUTANT LUNG CANCER